Review: Diagnosis of Helicobacter pylori infection.


Journal

Helicobacter
ISSN: 1523-5378
Titre abrégé: Helicobacter
Pays: England
ID NLM: 9605411

Informations de publication

Date de publication:
Sep 2019
Historique:
entrez: 6 9 2019
pubmed: 6 9 2019
medline: 1 1 2020
Statut: ppublish

Résumé

Endoscopic imaging of the stomach is improving. In addition to narrow band imaging, other methods, for example, blue light imaging and linked color imaging, are now available and can be combined with artificial intelligence systems to obtain information on the gastric mucosa and detect early gastric cancer. Immunohistochemistry is only recommended as an ancillary stain in case of chronic active gastritis without Helicobacter pylori detection by standard staining, and recommendations to exclude false negative H. pylori results have been made. Molecular methods using real-time PCR, droplet digital PCR, or amplification refractory mutation system PCR have shown a high accuracy, both for detecting H. pylori and for clarithromycin susceptibility testing, and can now be used in clinical practice for targeted therapy. The most reliable non-invasive test remains the

Identifiants

pubmed: 31486244
doi: 10.1111/hel.12641
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12641

Informations de copyright

© 2019 John Wiley & Sons Ltd.

Références

Okamura T, Iwaya Y, Kitahara K, Suga T, Tanaka E. Accuracy of endoscopic diagnosis for mild atrophic gastritis infected with Helicobacter pylori. Clin Endosc. 2018;51(4):362-367.
White JR, Sami SS, Reddiar D et al. Narrow band imaging and serology in the assessment of premalignant gastric pathology. Scand J Gastroenterol. 2018;53(12):1611-1618.
Akazawa Y, Ueyama H, Yao T et al. Usefulness of demarcation of differentiated-type early gastric cancers after Helicobacter pylori eradication by magnifying endoscopy with narrow-band imagine. Digestion. 2018;98(3):175-184.
Horiuchi Y, Fujisaki J, Yamamoto N et al. Diagnostic accuracy of demarcation using magnifying endoscopy with narrow-band imaging for Helicobacter pylori-uninfected undifferentiated-type early gastric cancer. Gastric Cancer. 2018;21(6):988-997.
Nishikawa Y, Ikeda Y, Murakami H et al. Classification of atrophic mucosal patterns on Blue laser Imaging for endoscopic diagnosis of Helicobacter pylori-related gastritis: a retrospective, observational study. PLoS ONE. 2018;13(3):e0193197.
Dohi O, Yagi N, Naito Y et al. Blue laser imaging-bright improves the real-time detection rate of early gastric cancer: a randomized controlled study. Gastrointest Endosc. 2019;89(1):47-57.
Chen TH, Hsu CM, Cheng HT et al. Linked color imaging can help gastric Helicobacter pylori infection diagnosis during endoscopy. J Chin Med Assoc. 2018;81(12):1033-1037.
Osawa H, Miura Y, Takezawa T et al. Linked color imaging and blue laser imaging for upper gastrointestinal screening. Clin Endosc. 2018;51(6):513-526.
Nakashima H, Kawahira H, Kawachi H, Sakaki N. Artificial intelligence diagnosis of Helicobacter pylori infection using blue laser imaging-bright and linked color imaging: a single-center prospective study. Ann Gastroenterol. 2018;31(4):462-468.
Shichijo S, Endo Y, Aoyama K et al. Application of convolutional neural networks for evaluating Helicobacter pylori infection status on the basis of endoscopic images. Scand J Gastroenterol. 2019;54(2):158-163.
Du Y, Fan K, Zhang H et al. Endoscopic molecular imaging of early gastric cancer using fluorescently labeled human H-ferritin nanoparticle. Nanomedicine. 2018;14(7):2259-2270.
Adachi K, Notsu T, Mishiro T, Kinoshita Y. Relationship of Helicobacter pylori infection with gastric black spots shown by endoscopy. Intern Med. 2019;58(6):767-772.
Hatano Y, Haruma K, Kamada T et al. Factors associated with gastric black spot, white flat elevated mucosa, and cobblestone-like mucosa: a cross-sectional study. Digestion. 2018;98(3):185-193.
Togo K, Ueo T, Yao K et al. White opaque substance visualized by magnifying narrow-band imaging is associated with intragastric acid conditions. Endosc Int Open. 2019;6(7):E830-E837.
Kotachi T, Ito M, Boda T et al. Clinical significance of reddish depressed lesions observed in the gastric mucosa after Helicobacter pylori eradication. Digestion. 2018;98(1):48-55.
Chen F, Liu Y, Tsay A, McAllister BP, Karamchandani DM. Hit or a miss: concordance between histopathologic-endoscopic findings in gastric mucosal biopsies. Ann Diagn Pathol. 2019;38:106-114.
Bertges LC, Dibai FN, Bezerra G, Oliveira ES, Aarestrup FM, Bertges KR. Comparison between the endoscopic findings and the histological diagnosis of antral gastrites. Arq Gastroenterol. 2018;55(3):212-215.
Pimentel-Nunes P, Libânio D, Marcos-Pinto R et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019;51(4):365-388.
Benoit A, Hoyeau N, Fléjou JF. Diagnosis of Helicobacter pylori infection on gastric biopsies: standard stain, special stain or immunohistochemistry? Ann Pathol. 2018;38(6):363-369.
El-Zimaity H, Choi WT, Lauwers GY, Riddell R. The differential diagnosis of Helicobacter pylori negative gastritis. Virchows Arch. 2018;473(5):533-550.
Rugge M, Genta RM, OLGA Group. Staging gastritis: an international proposal. Gastroenterology. 2005;129(5):1807-1808.
Capelle LG, de Vries AC, Haringsma J et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc. 2010;71(7):1150-1158.
Bellolio E, Riquelme I, Riffo-Campos AL et al. Assessment of gastritis and gastric cancer risk in the Chilean population using the OLGA system. Pathol Oncol Res. 2018; https://doi.org/10.1007/s12253-018-0532-3.
Mera RM, Bravo LE, Camargo MC et al. Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial. Gut. 2018;67(7):1239-1246.
Dechant FX, Dechant R, Kandulski A et al. Accuracy of different rapid urease tests in comparison with histopathology in patients with endoscopic signs of gastritis. Digestion. 2019;28:1-7.
Baroni MR, Bucci P, Giani RN et al. Usefulness of rapid urease test samples for molecular analysis of clarithromycin resistance in Helicobacter pylori. Rev Argent Microbiol. 2018;50:359-364.
Bénéjat L, Ducournau A, Lehours P, Mégraud F. Real-time PCR for Helicobacter pylori diagnosis. The best tools available. Helicobacter. 2018;23:e12512.
Hays C, Delerue T, Lamarque D et al. Molecular diagnosis of Helicobacter pylori infection in gastric biopsies: evaluation of the Amplidiag® H. pylori + ClariR assay. Helicobacter. 2019;24:e12560.
Sun L, Talarico S, Yao L et al. Droplet digital PCR-based detection of clarithromycin resistance in Helicobacter pylori isolates reveals frequent heteroresistance. J Clin Microbiol. 2018;56:e00019-18.
Talarico S, Korson AS, Leverich CK et al. High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR. Helicobacter. 2018;23:e12472.
Bazin T, Nchare Mfondi A, Julie C, Émile JF, Raymond J, Lamarque D. Contribution of genetic amplification by PCR for the diagnosis of Helicobacter pylori infection in patients receiving proton pump inhibitors. United European Gastroenterol J. 2018;6:1267-1273.
Hsieh M-S, Liu C-J, Hsu W-H et al. Gastric juice-based PCR assay: an alternative testing method to aid in the management of previously treated Helicobacter pylori infection. Helicobacter. 2019;24:e12568.
Bachir M, Allem R, Benejat L et al. Molecular detection of mutations involved in Helicobacter pylori antibiotic resistance in Algeria. J Antimicrob Chemother. 2018;73:2034-2038.
Blümel B, Goelz H, Kist M, Glocker E-O. Retrospective study on outcome of salvage Helicobacter pylori eradication therapies based on molecular genetic susceptibility testing. Helicobacter. 2018;23:e12494.
Cho JH, Jeon SR, Kim HG, Jin SY, Park S. Cost-effectiveness of a tailored Helicobacter pylori eradication strategy based on the presence of a 23S ribosomal RNA point mutation that causes clarithromycin resistance in Korean patients. J Gastroenterol Hepatol. 2019;34:700-706.
Gweon TG, Kim JS, Kim BW. An economic modeling study of Helicobacter pylori eradication: comparison of dual priming oligonucleotide-based multiplex polymerase chain reaction and empirical treatment. Gut Liv. 2018;12:648-654.
Zhang XY, Shen WX, Chen CF, Sheng HH, Cheng H, Li J. Detection of the clarithromycin resistance of Helicobacter pylori in gastric mucosa by the amplification refractory mutation system combined with quantitative real-time PCR. Cancer Med. 2019;8:1633-1640.
Iannone A, Giorgio F, Russo F et al. New fecal test for non-invasive Helicobacter pylori detection: a diagnostic accuracy study. World J Gastroenterol. 2018;24:3021-3029.
Yu J, Xu Q, Zhang X, Zhu M. Circulating microRNA signatures serve as potential diagnostic biomarkers for Helicobacter pylori infection. J Cell Biochem. 2019;120:1735-1741.
Graham DY, Miftahussurur M. Helicobacter urease for diagnosis of Helicobacter infection: a minireview. Journal of Advanced Research. 2018;13:51-57.
Eisdorfer I, Shalev V, Goren S, Chodick G, Muhsen K. Sex differences in the urea breath test results for the diagnosis of Helicobacter pylori infection: a large cross sectional study. Biol Sex Diff. 2018;9:1-8.
Perets TT, Gingold-Belfer R, Leibovitzh H et al. Optimization of 13C-urea breath test threshold levels for the detection of Helicobacter pylori in a national referral laboratory. J Clin Lab Anal. 2019;33:e22674.
Boltin D, Levi Z, Perets TT et al. Correlation between quantitative 13C-urea breath test and Helicobacter pylori treatment success in a population-based cohort. Gastroenterol Res Pract. 2018;2018:1-6.
Coelho LG, Sant'Ana CR, Oliveira RB et al. Performance of the 13C-urea breath test for the diagnosis of Helicobacter pylori infection using a substrate synthesized in Brazil: a preliminary study. Clinics. 2018;73:e16-e553.
Best LM, Takwoingi Y, Siddique S et al. Non-invasive diagnostic tests for Helicobacter pylori infection. Cochrane Database Syst Rev. 2018;3:CD012080. https://doi.org/10.1002/14651858.CD012080.pub2.
Shafaie E, Saberi S, Esmaeili M et al. Multiplex serology of Helicobacter pylori antigens in detection of current infection and atrophic gastritis - A simple and cost-efficient method. Microb Pathog. 2018;119:137-144.
Epplein M, Butt J, Zhang Y et al. Validation of a blood biomarker for identification of individuals at high risk for gastric cancer. Cancer Epidemiol Biomarkers Prev. 2018;27:1472-1476.
Butt J, Varga MG, Blot WJ et al. Serologic response to Helicobacter pylori proteins associated with risk of colorectal cancer among diverse populations in the United States. Gastroenterology. 2018;156:175-186.
Skrebinska S, Daugule I, Santare D et al. Accuracy of two plasma antibody tests and faecal antigen test for non-invasive detection of Helicobacter pylori in middle-aged Caucasian general population sample. Scand J Gastroenterol. 2018;53:777-783.
Syrjänen K, Eskelinen M, Peetsalu A et al. GastroPanel® biomarker assay: the most comprehensive test for Helicobacter pylori infection and its clinical sequelae. A critical review. Anticancer Res. 2019;39:1091-1104.
Moubri M, Burucoa C, Kalach N et al. Performances of the IDEIA HpStAR stool antigen test in detection of Helicobacter pylori infection before and after eradication treatment in Algerian children. J Trop Pediatr. 2018; 65:210-216.
Kakiuchi T, Okuda M, Hashiguchi K, Imamura I, Nakayama A, Matsuo M. Evaluation of a novel stool antigen rapid test kit for detection of Helicobacter pylori infection. J Clin Microbiol. 2019;57:e01825-18.
Kawano K, Yazumi S, Kawano R, Nishi K. Detection capability of the stool Helicobacter pylori antigen kit using gastric juice collected during esophagogastroduodenoscopy. Chin Med J. 2018;131:2252-2253.
El-Serag HB, Kao JY, Kanwal F et al. Houston Consensus Conference on testing for Helicobacter pylori infection in the United States. Clin Gastroenterol Hepatol. 2018;16:992-1002.

Auteurs

Athanasios Makristathis (A)

Division for Clinical Microbiology, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

Alexander M Hirschl (AM)

Division for Clinical Microbiology, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

Francis Mégraud (F)

French National Reference Center for Campylobacters and Helicobacters, Bacteriology Laboratory, CHU Pellegrin, Bordeaux, France.
INSERM, UMR1053, BaRITOn, University of Bordeaux, Bordeaux, France.

Emilie Bessède (E)

French National Reference Center for Campylobacters and Helicobacters, Bacteriology Laboratory, CHU Pellegrin, Bordeaux, France.
INSERM, UMR1053, BaRITOn, University of Bordeaux, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH